Adverse Effects of Thalidomide Administration, in Patients with Myeloma Multiplex?

INTRODUCTION: Myeloma multiplex is defined by the presence of monoclonal plasma cell population in the bone marrow>10%,M protein in the serum and/or urine ,and clinical evidence of end organ damage like hypercalcemia ,renal failure, anemia, or bone lesions. In the most hematologic malignancies th...

Descripción completa

Detalles Bibliográficos
Autores principales: Svetlana Balkanov, Krstevska, Sotirova, Tatjana, Genadieva, Stavrik Sonja, Cevreska, Lidija, Stojanovik, Aleksandar, Balkanov, Trajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035132/
https://www.ncbi.nlm.nih.gov/pubmed/24944541
http://dx.doi.org/10.5455/msm.2014.26.134-136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035132/
https://www.ncbi.nlm.nih.gov/pubmed/24944541
http://dx.doi.org/10.5455/msm.2014.26.134-136

Ejemplares similares